Literature DB >> 31547009

Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies.

Mark Vink1, Friso Vink-Niese2.   

Abstract

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome leads to severe functional impairment and work disability in a considerable number of patients. The majority of patients who manage to continue or return to work, work part-time instead of full time in a physically less demanding job. The prognosis in terms of returning to work is poor if patients have been on long-term sick leave for more than two to three years. Being older and more ill when falling ill are associated with a worse employment outcome. Cognitive behavioural therapy and graded exercise therapy do not restore the ability to work. Consequently, many patients will eventually be medically retired depending on the requirements of the retirement policy, the progress that has been made since they have fallen ill in combination with the severity of their impairments compared to the sort of work they do or are offered to do. However, there is one thing that occupational health physicians and other doctors can do to try and prevent chronic and severe incapacity in the absence of effective treatments. Patients who are given a period of enforced rest from the onset, have the best prognosis. Moreover, those who work or go back to work should not be forced to do more than they can to try and prevent relapses, long-term sick leave and medical retirement.

Entities:  

Keywords:  CFS (Chronic Fatigue Syndrome); ME (Myalgic Encephalomyelitis); medical retirement; prognosis; work rehabilitation

Year:  2019        PMID: 31547009     DOI: 10.3390/diagnostics9040124

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  8 in total

Review 1.  The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.

Authors:  Mark Vink; Alexandra Vink-Niese
Journal:  Healthcare (Basel)       Date:  2022-05-12

2.  An Audit of UK Hospital Doctors' Knowledge and Experience of Myalgic Encephalomyelitis.

Authors:  Keng Ngee Hng; Keith Geraghty; Derek F H Pheby
Journal:  Medicina (Kaunas)       Date:  2021-08-27       Impact factor: 2.948

Review 3.  Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?

Authors:  Mark Vink; Friso Vink-Niese
Journal:  Healthcare (Basel)       Date:  2022-02-18

4.  Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.

Authors:  Liam Townsend; Adam H Dyer; Karen Jones; Jean Dunne; Aoife Mooney; Fiona Gaffney; Laura O'Connor; Deirdre Leavy; Kate O'Brien; Joanne Dowds; Jamie A Sugrue; David Hopkins; Ignacio Martin-Loeches; Cliona Ni Cheallaigh; Parthiban Nadarajan; Anne Marie McLaughlin; Nollaig M Bourke; Colm Bergin; Cliona O'Farrelly; Ciaran Bannan; Niall Conlon
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

5.  Well-Being at Work after Return to Work (RTW): A Systematic Review.

Authors:  José-María Figueredo; Cristina García-Ael; Andrea Gragnano; Gabriela Topa
Journal:  Int J Environ Res Public Health       Date:  2020-10-15       Impact factor: 3.390

6.  The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).

Authors:  Derek F H Pheby; Diana Araja; Uldis Berkis; Elenka Brenna; John Cullinan; Jean-Dominique de Korwin; Lara Gitto; Dyfrig A Hughes; Rachael M Hunter; Dominic Trepel; Xia Wang-Steverding
Journal:  Medicina (Kaunas)       Date:  2021-04-16       Impact factor: 2.430

Review 7.  Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome.

Authors:  Mark Vink; Alexandra Vink-Niese
Journal:  Healthcare (Basel)       Date:  2020-12-11

8.  Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome.

Authors:  Andrea Dressing; Tobias Bormann; Ganna Blazhenets; Nils Schroeter; Lea I Walter; Johannes Thurow; Dietrich August; Hanna Hilger; Katarina Stete; Kathrin Gerstacker; Susan Arndt; Alexander Rau; Horst Urbach; Siegbert Rieg; Dirk Wagner; Cornelius Weiller; Philipp T Meyer; Jonas A Hosp
Journal:  J Nucl Med       Date:  2021-10-14       Impact factor: 11.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.